Endocrine-related cancer, ‎1351-0088

Journal

Publications

  1. Article › Research › Peer-reviewed
  2. Published

    STX2171, a 17β-hydroxysteroid dehydrogenase type 3 inhibitor, is efficacious in vivo in a novel hormone-dependent prostate cancer model

    Paul Foster, , , , , , , & , 2013, In: Endocrine-related cancer. 20, 1, p. 53-64 12 p.

    Research output: Contribution to journalArticlepeer-review

  3. Accepted/In press

    THE IGF2 METHYLATION SCORE FOR ADRENOCORTICAL CANCER: AN ENSAT VALIDATION STUDY

    Cristina Ronchi, , , , , , , , , , , , & , 13 Jul 2020, (Accepted/In press) In: Endocrine-related cancer.

    Research output: Contribution to journalArticlepeer-review

  4. Published

    The management of head-and-neck paragangliomas

    Niki Karavitaki & , Oct 2013, In: Endocrine-related cancer. 20, 5, p. R291-305

    Research output: Contribution to journalArticlepeer-review

  5. Published

    Thyroid stimulating hormone in thyroid cancer: does it matter?

    Hannah Nieto & Kristien Boelaert, 1 Nov 2016, In: Endocrine-related cancer. 23, 11, ERC-16-0328.

    Research output: Contribution to journalArticlepeer-review

  6. Special issue › Research › Peer-reviewed
  7. Published

    WOMEN IN CANCER PROFILE: From bedside to bench and back: my journey in thyroid disease

    Kristien Boelaert, Nov 2016, In: Endocrine-related cancer. 23, 11, p. 9-13

    Research output: Contribution to journalSpecial issuepeer-review

  8. Article › Research
  9. Published

    The 8q24 rs6983267G variant is associated with increased thyroid cancer risk

    Oct 2015, Endocrine-related cancer, 22, 5, p. 841-849.

    Research output: Contribution to specialist publicationArticle

  10. Review article › Research › Not peer-reviewed
  11. Published

    von Hippel Lindau disease and endocrine tumour susceptibility

    Emma Woodward & Eamonn Maher, 1 Jun 2006, In: Endocrine-related cancer. 13, 2, p. 415-425 11 p.

    Research output: Contribution to journalReview article

Previous 1 2 3 Next